Magnetic resonance imaging–based risk calculators optimize selection for prostate biopsy among biopsy‐naive men
Risk calculators have been created on the basis of predictive modeling to aid clinicians and patients in deciding whether to pursue prostate biopsy. Ideally, these risk calculators would reduce the diagnosis of low‐risk prostate cancer and increase the diagnosis of clinically significant prostate ca...
Gespeichert in:
Veröffentlicht in: | Cancer 2022-01, Vol.128 (1), p.25-27 |
---|---|
Hauptverfasser: | , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 27 |
---|---|
container_issue | 1 |
container_start_page | 25 |
container_title | Cancer |
container_volume | 128 |
creator | Fang, Andrew M. Rais‐Bahrami, Soroush |
description | Risk calculators have been created on the basis of predictive modeling to aid clinicians and patients in deciding whether to pursue prostate biopsy. Ideally, these risk calculators would reduce the diagnosis of low‐risk prostate cancer and increase the diagnosis of clinically significant prostate cancer. However, before these prediction models are to be available for widespread use, they must be carefully validated, discriminated, and calibrated to ensure their performance and applicability. |
doi_str_mv | 10.1002/cncr.33872 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2564137816</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2610470002</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3932-23e9d4ae9fcbb673b9eb9574d0415c6a7db71947a8cb68d06309a75d36aad08a3</originalsourceid><addsrcrecordid>eNp9kc2KFDEUhYMoTju68QEk4EaEGvNXlcpSGv9gVBAFd-EmdbvJWJW0SdVIu5pHEHzDeRIzduvChavLgY_DuecQ8pCzM86YeOajz2dS9lrcIivOjG4YV-I2WTHG-qZV8vMJuVfKRZVatPIuOZFKCW0UW5HyFrYR5-BpxpIiRI80TLANcXt99dNBwYHmUL5QD6NfRphTLjTt5jCF70gLjujnkCLdpEx3OZUZZqQupF3ZU5hS3B7F9dWPCOES6YTxPrmzgbHgg-M9JZ9evvi4ft2cv3_1Zv38vPHSSNEIiWZQgGbjneu0dAadabUamOKt70APTnOjNPTedf3AOskM6HaQHcDAepCn5MnBtwb7umCZ7RSKx3GEiGkpVrSd4lL3vKvo43_Qi7TkWNNZ0XGmdO1OVOrpgfL105JxY3e5lpX3ljN7M4W9mcL-nqLCj46Wi5tw-Iv-6b4C_AB8CyPu_2Nl1-_WHw6mvwC2IJes</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2610470002</pqid></control><display><type>article</type><title>Magnetic resonance imaging–based risk calculators optimize selection for prostate biopsy among biopsy‐naive men</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Wiley Free Content</source><source>Alma/SFX Local Collection</source><creator>Fang, Andrew M. ; Rais‐Bahrami, Soroush</creator><creatorcontrib>Fang, Andrew M. ; Rais‐Bahrami, Soroush</creatorcontrib><description>Risk calculators have been created on the basis of predictive modeling to aid clinicians and patients in deciding whether to pursue prostate biopsy. Ideally, these risk calculators would reduce the diagnosis of low‐risk prostate cancer and increase the diagnosis of clinically significant prostate cancer. However, before these prediction models are to be available for widespread use, they must be carefully validated, discriminated, and calibrated to ensure their performance and applicability.</description><identifier>ISSN: 0008-543X</identifier><identifier>EISSN: 1097-0142</identifier><identifier>DOI: 10.1002/cncr.33872</identifier><identifier>PMID: 34427940</identifier><language>eng</language><publisher>United States: Wiley Subscription Services, Inc</publisher><subject>Biopsy ; Calculators ; Diagnosis ; Health risks ; Humans ; Magnetic Resonance Imaging ; Male ; MRI ; nomogram ; Prediction models ; Prostate - diagnostic imaging ; Prostate - pathology ; prostate biopsy ; Prostate cancer ; Prostate-Specific Antigen ; Risk ; risk calculator</subject><ispartof>Cancer, 2022-01, Vol.128 (1), p.25-27</ispartof><rights>2021 American Cancer Society</rights><rights>2022 American Cancer Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c3932-23e9d4ae9fcbb673b9eb9574d0415c6a7db71947a8cb68d06309a75d36aad08a3</citedby><cites>FETCH-LOGICAL-c3932-23e9d4ae9fcbb673b9eb9574d0415c6a7db71947a8cb68d06309a75d36aad08a3</cites><orcidid>0000-0002-2390-7575 ; 0000-0001-9466-9925</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fcncr.33872$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fcncr.33872$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1416,1432,27922,27923,45572,45573,46407,46831</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/34427940$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Fang, Andrew M.</creatorcontrib><creatorcontrib>Rais‐Bahrami, Soroush</creatorcontrib><title>Magnetic resonance imaging–based risk calculators optimize selection for prostate biopsy among biopsy‐naive men</title><title>Cancer</title><addtitle>Cancer</addtitle><description>Risk calculators have been created on the basis of predictive modeling to aid clinicians and patients in deciding whether to pursue prostate biopsy. Ideally, these risk calculators would reduce the diagnosis of low‐risk prostate cancer and increase the diagnosis of clinically significant prostate cancer. However, before these prediction models are to be available for widespread use, they must be carefully validated, discriminated, and calibrated to ensure their performance and applicability.</description><subject>Biopsy</subject><subject>Calculators</subject><subject>Diagnosis</subject><subject>Health risks</subject><subject>Humans</subject><subject>Magnetic Resonance Imaging</subject><subject>Male</subject><subject>MRI</subject><subject>nomogram</subject><subject>Prediction models</subject><subject>Prostate - diagnostic imaging</subject><subject>Prostate - pathology</subject><subject>prostate biopsy</subject><subject>Prostate cancer</subject><subject>Prostate-Specific Antigen</subject><subject>Risk</subject><subject>risk calculator</subject><issn>0008-543X</issn><issn>1097-0142</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2022</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kc2KFDEUhYMoTju68QEk4EaEGvNXlcpSGv9gVBAFd-EmdbvJWJW0SdVIu5pHEHzDeRIzduvChavLgY_DuecQ8pCzM86YeOajz2dS9lrcIivOjG4YV-I2WTHG-qZV8vMJuVfKRZVatPIuOZFKCW0UW5HyFrYR5-BpxpIiRI80TLANcXt99dNBwYHmUL5QD6NfRphTLjTt5jCF70gLjujnkCLdpEx3OZUZZqQupF3ZU5hS3B7F9dWPCOES6YTxPrmzgbHgg-M9JZ9evvi4ft2cv3_1Zv38vPHSSNEIiWZQgGbjneu0dAadabUamOKt70APTnOjNPTedf3AOskM6HaQHcDAepCn5MnBtwb7umCZ7RSKx3GEiGkpVrSd4lL3vKvo43_Qi7TkWNNZ0XGmdO1OVOrpgfL105JxY3e5lpX3ljN7M4W9mcL-nqLCj46Wi5tw-Iv-6b4C_AB8CyPu_2Nl1-_WHw6mvwC2IJes</recordid><startdate>20220101</startdate><enddate>20220101</enddate><creator>Fang, Andrew M.</creator><creator>Rais‐Bahrami, Soroush</creator><general>Wiley Subscription Services, Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>7U7</scope><scope>C1K</scope><scope>H94</scope><scope>K9.</scope><scope>NAPCQ</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-2390-7575</orcidid><orcidid>https://orcid.org/0000-0001-9466-9925</orcidid></search><sort><creationdate>20220101</creationdate><title>Magnetic resonance imaging–based risk calculators optimize selection for prostate biopsy among biopsy‐naive men</title><author>Fang, Andrew M. ; Rais‐Bahrami, Soroush</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3932-23e9d4ae9fcbb673b9eb9574d0415c6a7db71947a8cb68d06309a75d36aad08a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2022</creationdate><topic>Biopsy</topic><topic>Calculators</topic><topic>Diagnosis</topic><topic>Health risks</topic><topic>Humans</topic><topic>Magnetic Resonance Imaging</topic><topic>Male</topic><topic>MRI</topic><topic>nomogram</topic><topic>Prediction models</topic><topic>Prostate - diagnostic imaging</topic><topic>Prostate - pathology</topic><topic>prostate biopsy</topic><topic>Prostate cancer</topic><topic>Prostate-Specific Antigen</topic><topic>Risk</topic><topic>risk calculator</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Fang, Andrew M.</creatorcontrib><creatorcontrib>Rais‐Bahrami, Soroush</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Premium</collection><collection>MEDLINE - Academic</collection><jtitle>Cancer</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Fang, Andrew M.</au><au>Rais‐Bahrami, Soroush</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Magnetic resonance imaging–based risk calculators optimize selection for prostate biopsy among biopsy‐naive men</atitle><jtitle>Cancer</jtitle><addtitle>Cancer</addtitle><date>2022-01-01</date><risdate>2022</risdate><volume>128</volume><issue>1</issue><spage>25</spage><epage>27</epage><pages>25-27</pages><issn>0008-543X</issn><eissn>1097-0142</eissn><abstract>Risk calculators have been created on the basis of predictive modeling to aid clinicians and patients in deciding whether to pursue prostate biopsy. Ideally, these risk calculators would reduce the diagnosis of low‐risk prostate cancer and increase the diagnosis of clinically significant prostate cancer. However, before these prediction models are to be available for widespread use, they must be carefully validated, discriminated, and calibrated to ensure their performance and applicability.</abstract><cop>United States</cop><pub>Wiley Subscription Services, Inc</pub><pmid>34427940</pmid><doi>10.1002/cncr.33872</doi><tpages>3</tpages><orcidid>https://orcid.org/0000-0002-2390-7575</orcidid><orcidid>https://orcid.org/0000-0001-9466-9925</orcidid><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0008-543X |
ispartof | Cancer, 2022-01, Vol.128 (1), p.25-27 |
issn | 0008-543X 1097-0142 |
language | eng |
recordid | cdi_proquest_miscellaneous_2564137816 |
source | MEDLINE; Wiley Online Library Journals Frontfile Complete; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Wiley Free Content; Alma/SFX Local Collection |
subjects | Biopsy Calculators Diagnosis Health risks Humans Magnetic Resonance Imaging Male MRI nomogram Prediction models Prostate - diagnostic imaging Prostate - pathology prostate biopsy Prostate cancer Prostate-Specific Antigen Risk risk calculator |
title | Magnetic resonance imaging–based risk calculators optimize selection for prostate biopsy among biopsy‐naive men |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T22%3A23%3A10IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Magnetic%20resonance%20imaging%E2%80%93based%20risk%20calculators%20optimize%20selection%20for%20prostate%20biopsy%20among%20biopsy%E2%80%90naive%20men&rft.jtitle=Cancer&rft.au=Fang,%20Andrew%20M.&rft.date=2022-01-01&rft.volume=128&rft.issue=1&rft.spage=25&rft.epage=27&rft.pages=25-27&rft.issn=0008-543X&rft.eissn=1097-0142&rft_id=info:doi/10.1002/cncr.33872&rft_dat=%3Cproquest_cross%3E2610470002%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2610470002&rft_id=info:pmid/34427940&rfr_iscdi=true |